| Financial Year |
March 31 2023 |
| Monetary Funds |
1,099,150,081.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
168,583,158.44 |
| Advances to Suppliers |
9,424,054.81 |
| Other Receivables |
19,150,560.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
76,200,680.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,382,192.76 |
| Total Current Assets |
1,373,890,728.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
49,050,124.29 |
| Fixed Assetes |
4,645,864,785.92 |
| Under-construction Projects |
46,351.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,525,427.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
465,677.68 |
| Deferred Income Tax Assets |
29,024,652.19 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
4,755,592,231.63 |
| Total Assets |
6,129,482,959.85 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
101,384,417.94 |
| Accounts Received In Advance |
2,932,435.36 |
| Employee Compensation Payable |
13,189,331.88 |
| Taxes Payable |
42,793,324.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
133,666,777.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,830,837.95 |
| Other Current Liabilities |
799,758,344.19 |
| Sub-Total of Current Liabilities |
1,185,805,451.20 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
750,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,123,135.92 |
| Total Liabilities |
1,189,928,587.12 |
| Paid-In Capital(Or Share Stock) |
1,350,395,121.00 |
| Capital Surplus |
661,345,590.79 |
| Surplus Reserve |
308,273,356.82 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,272,602,644.19 |
| Minority Stockholder's Interest |
346,937,659.93 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,592,616,712.80 |
| Owner's Equity（Stockholder's Equity） |
4,939,554,372.73 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,129,482,959.85 |
